Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.

Clinical trial NCT01525199 · COMPLETED

Trial details

NCT number: NCT01525199
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Stage IIIB/IV Non-Small Cell Lung Cancer

Start date: 2012-05-01
Primary completion: 2013-11-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.